Cohen & Company Inc. (COHN)
+0.56 (5.53%)
May 17, 2024, 4:00 PM EDT - Market closed

Company Description

Cohen & Company Inc. is a publicly owned investment manager.

The firm primarily provides its services to individuals and institutions. It manages separate client-focused fixed income portfolios.

Institutional Financial Markets, Inc. also manages funds and collateralized debt obligations for its clients.

It invests in the fixed income and alternative investment markets across the globe. The firm's fixed income investments include U.S. trust preferred securities, European hybrid capital securities, Asian commercial real estate debt, mortgage backed securities, and asset backed securities.

The firm was formerly known as Institutional Financial Markets, Inc. Cohen & Company Inc. was founded in 1999 and is based in Philadelphia, Pennsylvania with additional offices in New York City; Boca Raton, Florida; Chicago, Illinois; Bethesda, Maryland; Boston, Massachusetts; Paris, France; and London, United Kingdom.

Cohen & Company Inc.
Cohen & Company logo
Country United States
Founded 1999
Industry Capital Markets
Sector Financials
Employees 118
CEO Lester Raymond Brafman

Contact Details

Cira Centre, 2929 Arch Street, 17th Floor
Philadelphia, Pennsylvania 19104-2870
United States
Phone 215-701-9555

Stock Details

Ticker Symbol COHN
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001270436
CUSIP Number 19249M102
ISIN Number US19249M1027
Employer ID 16-1685692
SIC Code 6211

Key Executives

Name Position
Daniel Gideon Cohen Executive Chairman
Lester Raymond Brafman Chief Executive Officer
Joseph William Pooler Jr. Executive Vice President, Chief Financial Officer and Treasurer
Douglas Listman B.S., CPA Chief Accounting Officer and Assistant Treasurer
Dennis James Crilly J.D. General Counsel and Secretary
John Miles Butler Managing Director of U.S. Insurance Strategy
Andrew Kenneth Davilman Chief Operating Officer of Asset Management
Solomon Cohen Portfolio Manager

Latest SEC Filings

Date Type Title
May 6, 2024 EFFECT Notice of Effectiveness
May 6, 2024 10-Q Quarterly Report
May 6, 2024 8-K Current Report
May 2, 2024 S-3/A [Amend] Registration statement under Securities Act of 1933
Apr 19, 2024 ARS Filing
Apr 19, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 19, 2024 DEF 14A Other definitive proxy statements
Mar 6, 2024 10-K Annual Report
Mar 6, 2024 8-K Current Report
Jan 29, 2024 8-K Current Report